Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spring Bank Pharmaceuticals, Inc. | 0 | reported | 08 Mar 2023 | tx 17+211,396−184,959 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Mar 2023 | TENDER | Spring Bank Pharmaceuticals, Inc. | 29,236 | 7.12 USD | |
| 08 Mar 2023 | OTHER | Spring Bank Pharmaceuticals, Inc. | 25,019 | 7.12 USD | |
| 08 Mar 2023 | OTHER | Spring Bank Pharmaceuticals, Inc. | 12,880 | — | deriv |
| 08 Mar 2023 | OTHER | Spring Bank Pharmaceuticals, Inc. | 53,634 | — | deriv |
| 08 Mar 2023 | OTHER | Spring Bank Pharmaceuticals, Inc. | 27,289 | — | deriv |
| 08 Mar 2023 | OTHER | Spring Bank Pharmaceuticals, Inc. | 35,719 | — | deriv |
| 31 Mar 2022 | GRANT_AWARD | Spring Bank Pharmaceuticals, Inc. | 35,719 | 0.00 USD | deriv |
| 09 Jan 2022 | GRANT_AWARD | Spring Bank Pharmaceuticals, Inc. | 53,634 | 0.00 USD | deriv |
| 02 Nov 2021 | SALE | Spring Bank Pharmaceuticals, Inc. | 25 | 6.85 USD | |
| 02 Nov 2021 | SALE | Spring Bank Pharmaceuticals, Inc. | 39 | 6.81 USD | |
| 04 Oct 2021 | SALE | Spring Bank Pharmaceuticals, Inc. | 64 | 7.23 USD | |
| 02 Jul 2021 | SALE | Spring Bank Pharmaceuticals, Inc. | 1,054 | 8.43 USD | |
| 09 Mar 2021 | GRANT_AWARD | Spring Bank Pharmaceuticals, Inc. | 12,880 | 0.00 USD | deriv |
| 01 Feb 2021 | GRANT_AWARD | Spring Bank Pharmaceuticals, Inc. | 29,000 | 0.00 USD | |
| 20 Nov 2020 | GRANT_AWARD | Spring Bank Pharmaceuticals, Inc. | 27,289 | 0.00 USD | deriv |
| 20 Nov 2020 | GRANT_AWARD | Spring Bank Pharmaceuticals, Inc. | 26,437 | 0.00 USD | deriv |